Path ID: DB00508_MESH_D011618_5
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:D014273 | Triflupromazine | Drug |
| UniProt:P41595 | 5-hydroxytryptamine receptor 2B | Protein |
| GO:0001820 | serotonin secretion | BiologicalProcess |
| MESH:D012701 | Serotonin | ChemicalSubstance |
| HP:0000738 | Hallucinations | PhenotypicFeature |
| HP:0000746 | Delusions | PhenotypicFeature |
| MESH:D011618 | Psychotic Disorders | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Triflupromazine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2B |
| 5-Hydroxytryptamine Receptor 2B | POSITIVELY REGULATES | Serotonin Secretion |
| Serotonin Secretion | POSITIVELY CORRELATED WITH | Serotonin |
| Serotonin | CONTRIBUTES TO | Hallucinations |
| Serotonin | CONTRIBUTES TO | Delusions |
| Hallucinations | MANIFESTATION OF | Psychotic Disorders |
| Delusions | MANIFESTATION OF | Psychotic Disorders |
Reference: